Slam Corp. - Quarter Report: 2023 March (Form 10-Q)
Table of Contents
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Cayman Islands |
001-40094 |
98-1211848 | ||
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(IRS Employer Identification No.) |
55 Hudson Yards, 47th Floor, Suite C New York, New York |
10001 | |
(Address Of Principal Executive Offices) |
(Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-fourth of one redeemable warrant |
SLAMU |
The Nasdaq Stock Market LLC (Nasdaq Capital Market) | ||
Class A ordinary shares included as part of the units |
SLAM |
The Nasdaq Stock Market LLC (Nasdaq Capital Market) | ||
Redeemable warrants included as part of the units |
SLAMW |
The Nasdaq Stock Market LLC (Nasdaq Capital Market) |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer | ☒ | Smaller reporting company | ☒ | |||
Emerging growth company | ☒ |
Table of Contents
SLAM CORP.
Form 10-Q
For the Quarter Ended March 31, 2023
Table of Contents
Table of Contents
Item 1. |
Condensed Financial Statements |
March 31, 2023 |
December 31, 2022 |
|||||||
(Unaudited) |
||||||||
Assets: |
||||||||
Current assets: |
||||||||
Cash |
$ | 8,002 | $ | 119,463 | ||||
Prepaid expenses |
797,803 | 305,545 | ||||||
|
|
|
|
|||||
Total current assets |
805,805 | 425,008 | ||||||
Cash and investments held in Trust Account |
262,009,246 | 583,460,070 | ||||||
|
|
|
|
|||||
Total Assets |
$ |
262,815,051 |
$ |
583,885,078 |
||||
|
|
|
|
|||||
Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit: |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 625,539 | $ | 34,090 | ||||
Accrued expenses |
1,373,808 | 1,076,474 | ||||||
|
|
|
|
|||||
Total current liabilities |
1,999,347 | 1,110,564 | ||||||
Promissory Note—related party |
3,247,000 | — | ||||||
Working capital loan—related party |
1,474,000 | 1,474,000 | ||||||
Derivative warrant liabilities |
5,912,920 | 2,313,750 | ||||||
Deferred underwriting commissions |
20,125,000 | 20,125,000 | ||||||
|
|
|
|
|||||
Total liabilities |
32,758,267 | 25,023,314 | ||||||
Commitments and Contingencies |
||||||||
Class A ordinary shares subject to possible redemption, $0.0001 par value; 25,335,163 shares and 57,500,000 shares at redemption value of $10.34 and $10.15 per share as of March 31, 2023 and December 31, 2022, respectively |
261,909,246 | 583,360,070 | ||||||
Shareholders’ Deficit: |
||||||||
Preference shares, $ 0.0001 5,000,000 and December 31, 2022 |
— | — | ||||||
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; no non-redeemable shares issued and outstanding as of March 31, 2023 and December 31, 2022 |
— | — | ||||||
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 14,375,000 shares issued and outstanding as of March 31, 2023 and December 31, 2022 |
1,438 | 1,438 | ||||||
Additional paid-in capital |
— | — | ||||||
Accumulated deficit |
(31,853,900 | ) | (24,499,744 | ) | ||||
|
|
|
|
|||||
Total shareholders’ deficit |
(31,852,462 | ) | (24,498,306 | ) | ||||
|
|
|
|
|||||
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit |
$ |
262,815,051 |
$ |
583,885,078 |
||||
|
|
|
|
For The Three Months Ended March 31, |
||||||||
2023 |
2022 |
|||||||
General and administrative expenses |
$ | 1,324,986 | $ | 1,017,357 | ||||
General and administrative expenses—related party |
30,000 | 30,000 | ||||||
Total operating expenses |
(1,354,986 | ) | (1,047,357 | ) | ||||
Other income: |
||||||||
Change in fair value of derivative warrant liabilities |
(3,599,170 | ) | 5,266,800 | |||||
Income from investments held in Trust Account |
4,241,206 | 46,930 | ||||||
Net income (loss) |
$ | (712,950 | ) | $ | 4,266,373 | |||
Weighted average shares outstanding of Class A ordinary shares, basic and diluted |
43,561,904 | 57,500,000 | ||||||
Basic and diluted net income (loss) per share, Class A ordinary shares |
$ | (0.01 | ) | $ | 0.06 | |||
Weighted average shares outstanding of Class B ordinary shares, basic and diluted |
14,375,000 | 14,375,000 | ||||||
Basic and diluted net income (loss) per share, Class B ordinary shares |
$ | (0.01 | ) | $ | 0.06 | |||
Ordinary Shares |
Additional |
Total |
||||||||||||||||||||||||||
Class A |
Class B |
Paid-In |
Accumulated |
Shareholders’ |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Capital |
Deficit |
Deficit |
||||||||||||||||||||||
Balance—December 31, 2022 |
— | $ | — | 14,375,000 |
$ |
1,438 |
$ | — | $ |
(24,499,744 |
) |
$ |
(24,498,306 |
) | ||||||||||||||
Increase in redemption value of Class A ordinary shares subject to possible redemption |
— | — | — | — | — | (6,641,206 | ) | (6,641,206 | ) | |||||||||||||||||||
Net loss |
— | — | — | — | — | (712,950 | ) | (712,950 | ) | |||||||||||||||||||
Balance—March 31, 2023 (unaudited) |
— | $ | — | 14,375,000 |
$ |
1,438 |
$ | — | $ |
(31,853,900 |
) |
$ |
(31,852,462 |
) | ||||||||||||||
Ordinary Shares |
Additional |
Total |
||||||||||||||||||||||||||
Class A |
Class B |
Paid-In |
Accumulated |
Shareholders’ |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Capital |
Deficit |
Deficit |
||||||||||||||||||||||
Balance—December 31, 2021 |
— | $ | — | 14,375,000 |
$ |
1,438 |
$ | — | $ |
(34,825,869 |
) |
$ |
(34,824,431 |
) | ||||||||||||||
Net income |
— | — | — | — | — | 4,266,373 | 4,266,373 | |||||||||||||||||||||
Balance—March 31, 2022 (unaudited) |
— | $ | — | 14,375,000 |
$ |
1,438 |
$ | — | $ |
(30,559,496 |
) |
$ |
(30,558,058 |
) | ||||||||||||||
For The Three Months Ended March 31, |
||||||||
2023 |
2022 |
|||||||
Cash Flows from Operating Activities: |
||||||||
Net income (loss) |
$ | (712,950 | ) | $ | 4,266,373 | |||
Adjustments to reconcile net income (loss) to net cash used in operating activities: |
||||||||
Change in fair value of derivative warrant liabilities |
3,599,170 | (5,266,800 | ) | |||||
Income from investments held in Trust Account |
(4,241,206 | ) | (46,930 | ) | ||||
Changes in operating assets and liabilities: |
||||||||
Prepaid expenses |
(492,258 | ) | 395,370 | |||||
Accounts payable |
591,449 | 30,307 | ||||||
Accrued expenses |
297,334 | 211,484 | ||||||
|
|
|
|
|||||
Net cash used in operating activities |
(958,461 |
) |
(410,196 |
) | ||||
|
|
|
|
|||||
Cash Flows from Investing Activities: |
||||||||
Cash deposited in Trust Account |
(2,400,000 | ) | — | |||||
Cash withdrawn for redemptions |
328,092,030 | — | ||||||
|
|
|
|
|||||
Net cash provided by investing activities |
325,692,030 |
— |
||||||
|
|
|
|
|||||
Cash Flows from Financing Activities: |
||||||||
Proceeds received from promissory note - related party |
3,247,000 | — | ||||||
Redemption of Public Shares |
(328,092,030 | ) | — | |||||
|
|
|
|
|||||
Net cash used in financing activities |
(324,845,030 |
) |
— |
|||||
|
|
|
|
|||||
Net change in cash |
(111,461 |
) |
(410,196 |
) | ||||
Cash—beginning of the period |
119,463 | 471,352 | ||||||
|
|
|
|
|||||
Cash—end of the period |
$ |
8,002 |
$ |
61,156 |
||||
|
|
|
|
• | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
• | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
For The Three Months Ended March 31, |
||||||||||||||||
2023 |
2022 |
|||||||||||||||
Class A |
Class B |
Class A |
Class B |
|||||||||||||
Basic and diluted net income (loss) per ordinary share: |
||||||||||||||||
Numerator: |
||||||||||||||||
Allocation of net income (loss), basic and diluted |
$ | (536,057 | ) | $ | (176,893 | ) | $ | 3,413,099 | $ | 853,274 | ||||||
Denominator: |
||||||||||||||||
Basic and diluted weighted average ordinary shares Outstanding |
43,561,904 | 14,375,000 | 57,500,000 | 14,375,000 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted net income (loss) per ordinary share |
$ | (0.01 | ) | $ | (0.01 | ) | $ | 0.06 | $ | 0.06 | ||||||
|
|
|
|
|
|
|
|
Class A ordinary shares subject to possible redemption at December 31, 2022 |
$ |
583,360,070 |
||
Less in redemption |
(328,092,030 | ) | ||
Deposit in connection with Extension Amendment Proposal |
2,400,000 | |||
Increase in redemption value of Class A ordinary shares subject to possible redemption |
4,241,206 | |||
Class A ordinary shares subject to possible redemption at March 31, 2023 |
$ |
261,909,246 |
||
• | in whole and not in part; |
• | at a price of $0.01 per warrant; |
• | upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and |
• | if, and only if, the last reported sale price (the “closing price”) of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. |
• | in whole and not in part; |
• | at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of Class A ordinary shares to be determined by reference to an agreed table based on the redemption date and the “fair market value” of Class A ordinary shares; |
• | if, and only if, the closing price of Class A ordinary shares equals or exceeds $10.00 per share (as adjusted) for any 20 trading days within the 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and |
• | if the closing price of the Class A ordinary shares for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. |
March 31, 2023 |
||||||||||||
Description |
Quoted Prices in Active Markets (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Other Unobservable Inputs (Level 3) |
|||||||||
Liabilities: |
||||||||||||
Derivative warrant liabilities-Public warrants |
$ | 3,306,250 | $ | — | $ | — | ||||||
Derivative warrant liabilities-Private placement warrants |
$ | — | $ | 2,606,670 | $ | — |
December 31, 2022 |
||||||||||||
Description |
Quoted Prices in Active Markets (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Other Unobservable Inputs (Level 3) |
|||||||||
Assets: |
||||||||||||
Investments held in Trust Account-Money market funds |
$ | 583,460,070 | $ | — | $ | — | ||||||
Liabilities: |
||||||||||||
Derivative warrant liabilities-Public warrants |
$ | 1,293,750 | $ | — | $ | — | ||||||
Derivative warrant liabilities-Private placement warrants |
$ | — | $ | 1,020,000 | $ | — |
Table of Contents
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations. |
References to the “Company,” “Slam Corp.,” “Slam,” “our,” “us” or “we” refer to Slam Corp. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited interim condensed financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other SEC filings.
Overview
We are a blank check company incorporated on December 18, 2020 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. We have not selected any business combination target. We intend to effectuate our initial business combination using cash from the proceeds of our Initial Public Offering (“IPO”) and the placement of the private placement warrants, the proceeds of the sale of our shares in connection with our initial business combination (pursuant to any forward purchase agreements or backstop agreements we may enter into), shares issued to the owners of the target, debt issued to bank or other lenders or the owners of the target, or a combination of the foregoing or other sources.
The issuance of additional shares in a business combination:
• | may significantly dilute the equity interest of investors in our IPO, which dilution would increase if the anti-dilution provisions in the Class B ordinary shares resulted in the issuance of Class A ordinary shares on a greater than one-to-one basis upon conversion of the Class B ordinary shares; |
• | may subordinate the rights of holders of Class A ordinary shares if preference shares are issued with rights senior to those afforded our Class A ordinary shares; |
• | could cause a change in control if a substantial number of our Class A ordinary shares are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors; |
• | may have the effect of delaying or preventing a change of control of us by diluting the share ownership or voting rights of a person seeking to obtain control of us; |
• | may adversely affect prevailing market prices for our units, Class A ordinary shares and/or warrants; and |
• | may not result in adjustment to the exercise price of our warrants. |
20
Table of Contents
Similarly, if we issue debt or otherwise incur significant debt, it could result in:
• | default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations; |
• | acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant; |
• | our immediate payment of all principal and accrued interest, if any, if the debt is payable on demand; |
• | our inability to obtain necessary additional financing if the debt contains covenants restricting our ability to obtain such financing while the debt is outstanding; |
• | our inability to pay dividends on our Class A ordinary shares; |
• | using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our Class A ordinary shares if declared, expenses, capital expenditures, acquisitions and other general corporate purposes; |
• | limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate; |
• | increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and |
• | limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt. |
As indicated in the accompanying unaudited condensed financial statements, as of March 31, 2023, we had approximately $8,000 in our operating bank account. Further, we expect to incur significant costs in the pursuit of our initial business combination. We cannot assure you that our plans to raise capital or to complete our initial business combination will be successful.
Results of Operations and Known Trends or Future Events
We have neither engaged in any operations nor generated any revenues to date. Our only activities since inception have been organizational activities and those necessary to prepare for our IPO. Following the IPO, we will not generate any operating revenues until after completion of our initial business combination. We will generate non-operating income in the form of interest income on cash and cash equivalents after our IPO. There has been no significant change in our financial or trading position and no material adverse change has occurred since the date of our audited financial statements. After our IPO, we have incurred increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.
For the three months ended March 31, 2023, we had net loss of approximately $700,000, which consisted of and approximately $1.4 million in general and administrative expenses and $3.6 million non-operating loss resulting from the change in fair value of derivative warrant liabilities, offset by approximately $4.2 million of income from investments and cash held in Trust Account.
For the three months ended March 31, 2022, we had net income of approximately $4.3 million, which consisted of approximately $47,000 of income from investments held in trust account and approximately $5.3 million non-operating gain resulting from the change in fair value of derivative warrant liabilities, offset by approximately $1.0 million in general and administrative expenses.
Liquidity and Going Concern Considerations
As of March 31, 2023, we had approximately $8,000 in our operating bank account and working capital deficit of approximately $1.2 million.
The Company’s liquidity needs through March 31, 2023 were satisfied through a contribution of $25,000 from the Sponsor to purchase Founder Shares (as defined in Note 4), the loan of approximately $196,000 from the Sponsor under the Note (as defined in Note 4), and the proceeds from the consummation of the Private Placement not held in the Trust Account. The Company repaid the Note in full on February 25, 2021. In addition, in order to finance transaction costs in connection with a business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 4). As of March 31, 2023 and December 31, 2022, there was $1,474,000 outstanding under the Working Capital Loans.
On February 21, 2023, the Company issued an unsecured promissory note in the total principal amount of up to $10,447,000 (the “New Note”) to the Sponsor. The Sponsor funded the initial principal amount of $3,247,000 on February 23, 2023. The New Note does not bear interest and matures upon closing of the Company’s initial business combination. As of March 31, 2023 and December 31, 2022, there was $3,247,000 and $0, respectively, outstanding under the New Note.
In connection with our assessment of going concern considerations in accordance with FASB ASU 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the liquidity condition, the date for mandatory liquidation and dissolution raise substantial doubt about our ability to continue as a going concern through May 25, 2023, our scheduled liquidation date if we do not complete the business combination prior to such date. We intend to complete a business combination by May 25, 2023 but cannot guarantee such event. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after May 25, 2023.
21
Table of Contents
Off-Balance Sheet Arrangements
As of March 31, 2023 and December 31, 2022, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.
Critical Accounting Estimates
The preparation of condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. As of March 31, 2023 and December 31, 2022, we did not have any critical accounting estimates to be disclosed.
JOBS Act
The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” and under the JOBS Act are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, our unaudited condensed financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.
Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the unaudited condensed financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the principal executive officer’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our IPO or until we are no longer an “emerging growth company,” whichever is earlier.
Item 3. | Quantitative and Qualitative Disclosures About Market Risk |
We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.
Item 4. | Controls and Procedures |
Evaluation of Disclosure Controls and Procedures
Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended March 31, 2023, as such term is defined in Rules 13a-15€ and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial officer has concluded that during the period covered by this report, our disclosure controls and procedures were effective as of March 31, 2023.
22
Table of Contents
Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting
There was no change in our internal control over financial reporting that occurred during the fiscal quarter ended March 31, 2023 covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
PART II-OTHER INFORMATION
Item 1. | Legal Proceedings |
None.
Item 1A. | Risk Factors |
As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K filed with the SEC on March 29, 2023. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities. |
None.
Item 3. | Defaults Upon Senior Securities |
None.
Item 4. | Mine Safety Disclosures. |
Not applicable.
Item 5. | Other Information. |
None.
23
Table of Contents
Item 6. | Exhibits. |
* | Filed herewith. |
** | Furnished herewith. |
24
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: May 15, 2023 | SLAM CORP. | |||||
By: | /s/ Himanshu Gulati | |||||
Name: | Himanshu Gulati | |||||
Title: | Chairman | |||||
(Principal Executive Officer) | ||||||
By: | /s/ Joseph Taeid | |||||
Name: | Joseph Taeid | |||||
Title: | Chief Financial Officer | |||||
(Principal Financial and Accounting Officer) |
25